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Incidence of epidemic Vibrio cholerae serogroup O139 has declined in cholera endemic
countries. However, sporadic cholera caused by V. cholerae O139 with notable genetic
changes is still reported from many regions. In the present study, 42 V. cholerae
O139 strains isolated from 2001 to 2006 in Delhi, India, were retrospectively analyzed
to understand their phenotype and molecular characteristics. The majority of isolates
were resistant to ampicillin, furazolidone and nalidixic acid. Though the integrative
conjugative element was detected in all the O139 isolates, the 2004–2006 isolates
remained susceptible to co-trimoxazole, chloramphenicol, and streptomycin. Cholera
toxin genotype 1 was present in the majority of the O139 isolates while few had type
3 or a novel type 4. In the cholera toxin encoding gene (ctx) restriction fragment length
polymorphism, the majority of the isolates harbored three copies of CTX element, of
which one was truncated. In this study, the ctx was detected for the first time in the small
chromosome of V. cholerae O139 and one isolate harbored 5 copies of CTX element,
of which 3 were truncated. The ribotype BII pattern was found in most of the O139
isolates. Three V. cholerae O139 isolated in 2001 had a new ribotype BVIII. Pulsed-field
gel electrophoresis analysis revealed clonal variation in 2001 isolates compared to the
2004–2006 isolates. Molecular changes in V. choleraeO139 have to be closely monitored
as this information may help in understanding the changing genetic features of this
pathogen in relation to the epidemiology of cholera.
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INTRODUCTION
The aquatic bacterium Vibrio cholerae is the causative agent of cholera or cholera-like diarrhea in
humans. Of the 206 serogroups identified in this species (Yamai et al., 1997), the serogroups O1
and O139 are responsible for global cholera epidemics. V. cholerae serogroup O1 is further divided
into two biotypes, classical and El Tor and each has two distinct serotypes, Inaba and Ogawa. The
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classical biotype was associated with cholera in first six pandemics
(Sack et al., 2004). The current 7th cholera pandemic is
represented by V. cholerae O1 El Tor biotype, which became
dominant from 1961 and gradually replaced the classical biotype
from the global cholera scenario. V. cholerae O139 serogroup
emerged in 1992 by replacing the El Tor biotype in the
Indian subcontinent and spread to more than 14 countries in
the following years (Nair et al., 1994a; Siddique et al., 1996;
Ramamurthy et al., 2003). Emergence of V. cholerae O139
serogroup was thought to be the beginning of the 8th cholera
pandemic considering the rapid spread of the pathogen (Nair
et al., 1994b). However, after causing large cholera epidemics
in 1993, the serogroup O139 disappeared abruptly from the
endemic scenario ensuing resurgence of V. cholerae O1 El Tor
biotype in cholera endemic regions (Sharma et al., 1997). Until
late 1999, there has been periodic shift between El Tor and O139
in India and Bangladesh (Basu et al., 2000; Faruque et al., 2003a).
In 2008, the incidence of V. cholerae O139 in China was 32%
among cholera cases (WHO, 2009) and continued until 2012
(Zhang et al., 2014).
In V. cholerae O139, changes in the antimicrobial
susceptibility patterns and arrangement of genetic elements,
especially the organization of ribosomal RNA operons, location,
and arrangement of cholera toxin prophages (CTX8) were
reported during its emergence on several occasions (Sharma
et al., 1997; Faruque et al., 2003a; Nandi et al., 2003; Chatterjee
et al., 2007; Ghosh et al., 2008). Initial genetic analysis showed
that emergence of V. cholerae O139 may be due to the insertion
of a novel 35-kb wbf gene that encodes O139-somatic (O)
antigen in a V. cholerae serogroup O22 strain or due to the loss
of a 22-kb wbe region in a V. cholerae O1 that encodes the O1
antigen (Yamasaki et al., 1999). The whole genome sequence
analysis by Chun et al. (2009) confirmed the above finding, i.e.,
substitution of the gene cluster coding for the O139 antigen took
place by horizontal gene transfer but not the deletion.
Based on the amino acid changes, the B-subunits of CT have
been designated into several CT-genotypes or ctxB alleles (Safa
et al., 2008; Raychoudhuri et al., 2009). CT genotyping (ctxB
allele) can be made using Mismatch amplification mutation assay
(MAMA) PCR (Morita et al., 2008). CT genotype 1 is reported in
strains of the classical biotype worldwide and in US Gulf Coast,
genotype 2 is found in El Tor biotype strains from Australia, and
genotype 3 is prevalent in El Tor biotype from the 7th pandemic
and the Latin American epidemic strains (Olsvik et al., 1993).
V. choleraeO1El Tor isolates that produces classical CT is a newly
emerged trait, which is said to be associated with the severity of
the illness (Siddique et al., 2010) with a large number of cholera
outbreaks (Nair et al., 2006; Safa et al., 2008; Raychoudhuri
et al., 2009). CT encoding genes of O1 and O139 serogroups is
carried by a filamentous CTX8, which is known to use the toxin-
coregulated pili (TCP) as its receptor (Waldor and Mekalanos,
1996). V. cholerae O139 harboring CTXclass8 and CTXcalc8 has
been described based on the difference in the sequence of rstR
that encodes for the repressor protein of the CTX8 (Faruque
et al., 2003a; Bhattacharya et al., 2006; Raychoudhuri et al., 2010).
This study was undertaken to understand the phenotype and
genetic changes of V. cholerae O139 isolated from sporadic
hospitalized cholera cases in Delhi during 2001–2006. The
outcome of this study may be useful to comprehend the
epidemiology of V. cholerae O139.
MATERIALS AND METHODS
Bacterial Strains
V. cholerae O139 was isolated from cholera patients admitted
at the Maharishi Valmiki Infectious Diseases Hospital, Delhi.
Between 2001 and 2006, 42 isolates individually isolated
strains were included in this study (Table 1). V. cholerae O1
569B (classical biotype), N16961 (El Tor biotype), and SG-24
(serogroup O139) were used as reference strains. In the pulsed-
field gel electrophoresis (PFGE), Salmonella enterica serotype
Braenderup strain H9812 was used as the molecular size
standard.
Bacteriology and Serotyping
V. cholerae isolates were grown on thiosulphate-citrate-bile
salt-sucrose (TCBS) agar (Eiken, Tokyo, Japan) at 37◦C for
16–18 h. Typical sucrose fermenting yellow colonies was further
streaked on Luria agar (LA, Difco, Detroit, MD, USA) and
subsequently used in the rapid biochemical identification (Nair
et al., 1987). Presumptively identified V. cholerae isolates were
further confirmed by oxidase test and confirmed serologically
by slide agglutination test using O1 and O139 monoclonal
antibodies prepared at the National Institute of Cholera and
Enteric Diseases, Kolkata, India (Garg et al., 1994; Ramamurthy
et al., 1995).
Antimicrobial Susceptibility
Antimicrobial susceptibility testing was performed using
commercially available disks (Difco) following the Clinical
and Laboratory Standard Institute guidelines (CLSI, 2014).
The concentration of antibiotics in the disc was as follows:
ampicillin (10µg), chloramphenicol (30µg), co-trimoxazole
(sulfamethoxazole/trimethoprim, 1.25/23.45µg), ciprofloxacin
(5µg), furazolidone (100µg), norfloxacin (10µg), gentamycin
(10µg), nalidixic acid (30µg), neomycin (30µg), streptomycin
(10µg), tetracycline (30µg), and erythromycin (15µg). Except
for furazolidone, the minimal inhibitory concentrations (MICs)
of antibiotics (ampicillin, chloramphenicol, erythromycin,
nalidixic acid, streptomycin, sulfamethoxazole/trimethoprim)
were determined by E-test (AB bioMérieux, Solna, Sweden).
Extraction of Chromosomal DNA
Modified method of Murray and Thompson (1980) was used for
V. cholerae genomic DNA extraction.
Polymerase Chain Reaction (PCR) Assay
Multiplex PCRs were used for the detection of rfb genes encoding
the somatic antigen of O139/O1, CT encoding gene (ctxA),
and biotypes based on the allelic difference in the tcpA gene
(Keasler and Hall, 1993; Hoshino et al., 1998). Simplex PCR
assays with specific primers were made for the detection of rstR
alleles (Bhattacharya et al., 2006). MAMA-PCR was made to
detect the presence of ctxB alleles (CT genotypes) as described
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TABLE 1 | Phenotypic and genetic characteristics of V. cholerae O139 isolates.
Isolate Year rstR
classical
rstR El Tor rstR cal ctxB* El Tor ctxB*
classical
Ribotype ctx copy Antibiogram MIC (µg/ml)
A Na S Co C E
2 2001 − + − − + BI 1 ACoS 3 − 64 4 − −
4 2001 − + − − + BI 1 ACoFzS 4 − 128 4 − −
21 2001 − + − − + BII 1 Fz − − − − − −
36 2001 − + − − + BI 1 CCoS − − 64 12 2 −
37 2001 + + + + + BVIII ND AFzNaS 3 >256 128 − − −
46 2001 + + + + + BVIII 2 + 3 TRN AFzNaSE 4 >256 >256 − − 1.5
103 2001 + + + + + BVIII ND NaS − >256 64 − − −
174 2001 − + − − + BII 1 ACFzS 3 − 64 − 4 −
262 2001 − + − − + BII 1 AFzS 4 − 128 − − −
274 2001 − + − − + BI 1 ACFzS 4 − >256 − 4 −
280 2001 − + − − + BII ND AFzS 3 − >256 − − −
X 2001 − + + + + BII ND ACCoFzNaS 3 16 64 4 4 −
3653 2004 − + + − + BII 2 + 1TRN AFzNa 4 >256 − − − −
3686 2004 − + + − + BII 2 + 1TRN AFzNa 6 >256 − − − −
3705 2004 − + + − + BII 2 + 1TRN AFzNa 6 16 − − − −
3710 2004 − + + − + BII 2 + 1TRN AFzNa 4 >256 − − − −
3711 2004 − + + − + BII 2 + 1TRN AFzNaE 12 16 − − − 1
3712 2004 − + + − + BII 2 + 1TRN AFzNa 6 >256 − − − −
3719 2004 − + + − + BII 2 + 1TRN FzNa − 16 − − − −
3722 2004 − + + − + BII 2 + 1TRN AFzNa 4 16 − − − −
3736 2004 − + + − + BII 2 + 1TRN AFzNa 6 16 − − − −
3784 2004 − + + − + BII 2 + 1TRN AFzNa 4 >256 − − − −
3786 2004 − + + − + BII ND AFzNa 6 >256 − − − −
3791 2004 − + + − + BII ND AFzNa 4 16 − − − −
3795 2004 − + + − + BII 2 + 1TRN AFzNa 4 12 − − − −
3796 2004 − + + − + BII 2 + 1TRN ANa 4 >256 − − − −
3799 2004 − + + − + BII 2 + 1TRN AFzNa 4 16 − − − −
3822 2004 − + + − + BII ND FzNa − 16 − − − −
3848 2004 − + + − + BII 2 + 1TRN AFzNa 4 8 − − − −
8/15 2004 − + + − + BII ND NaE − 16 − − − 1.5
24/6 2004 − + + − + BII ND ANa 4 >256 − − − −
12/17 2004 − + − − + BII ND A 4 − − − − −
OS-227 2004 − + + − + BII 2 + 1TRN FzNa − 64 − − − −
5037/05 2005 − + + − + BII 2 + 1TRN AFzNa 4 24 − − − −
130/06 2006 − + + − + BII 2 + 1TRN FzNa − 16 − − − −
4602/06 2006 − + + − + BII 2 + 1TRN AFzNa 6 >256 − − − −
5340/06 2006 − + + − + BII 2 + 1TRN AFzNa 8 >256 − − − −
5801/06 2006 − + + − + BII 2 + 1TRN AFzNa 6 24 − − − −
5932/06 2006 − + + − + BII 2 + 1TRN AFzNa 4 >256 − − − −
6080/06 2006 − + + − + BII 2 + 1TRN AFzNa 6 16 − − − −
6120/06 2006 − + + − + BII 2 + 1TRN AFzNa 3 64 − − − −
6127/06 2006 − + + − + BI 2 + 1TRN AFzNa 4 3 − − − −
*As identified by MAMA-PCR. Abbreviations; ND, not done; TRN, truncated gene; A, ampicillin; C, chloramphenicol; Co, co-trimoxazole; Fz, furazolidone; E, erythromycin, Na, nalidixic
acid; S, streptomycin.
All the isolates had ICE. floR, str, and dfr genes are present in the respective chloramphenicol, streptomycin, co-trimoxazole resistant V. cholerae O139 isolates of 2001.
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previously (Morita et al., 2008). Location of CTX prophage in
chromosome II was confirmed by PCR using published methods
(Maiti et al., 2006). To confirm the presence of integrative
conjugative element (ICE) that carries the SXT element, two
sets of primers were used in this study. Primers 10SF13 (5′-
TTGTGGTGGAAAGAGGGTG-3′), SXT-13 (5′-CCAACAAAG
AACAGTTTGACTC-3′), and ORF-16 (5′-CATCTACCACTT
CATAGGCAGG-3′), YND-2 (5′-CAGCTTAACTCACCAAGG
AC-3′) were designed using conserved right and left terminal
ends of the ICE, respectively. In addition, floR, str, and dfr
genes encoding chloramphenicol, streptomycin, co-trimoxazole
resistance was identified using published methods (Hochhut
et al., 2001). In these PCRs, V. cholerae 569B, N16961, and SG-
24 were used as reference strains. PCR assays were performed
using an automated thermocycler (Gene Amp PCR system 9700,
Applied Biosystems, Foster City, CA).
DNA Sequencing
The 460 bp region of ctxB gene was amplified by PCR from
eight representative isolates of V. cholerae O139 covering all the
years (Olsvik et al., 1993). The amplified product was purified
using a PCR purification kit (Qiagen, Hilden, Germany) and
used directly as a template for nucleotide sequencing. Both
the strands of DNA were sequenced with BigDye terminator
cycle sequencing kit using an automated sequencer ABI 3700
(Applied Biosystems). The nucleotide and amino acid sequences
were compared with the sequences available in the GenBank.
The nucleotide sequence data generated with five representative
isolates of V. cholerae O139 were submitted to the GenBank with
accession numbers from GQ892075 to GQ892079.
Ribotyping
A 7.5-kb BamH1 (Fermentas, Waltham, MA, USA) fragment
of plasmid pKK3535 containing the 16S and 23S rRNA genes
of Escherichia coli was used as a rRNA probe (Brosius et al.,
1981). Standard V. cholerae ribotyping was followed in this
study (Faruque et al., 2000). Instead of radioisotope, we used
chemiluminescent dye (Gene Images Alkaphos direct labeling
and detection system, Amersham Biosciences, UK) in the DNA
hybridization analysis.
ctxA RFLP
Restriction enzymes HindIII, PstI, and BglII (Fermentas) were
used for the digestion of V. cholerae O139 chromosomal
DNA and immobilized on nylon membranes (Amersham
International). The CT encoding gene (ctxA) probe was a 540-
bp XbaI-ClaI (Fermentas) fragment cloned into the plasmid
pKTN901 using EcoR1 linkers (Kaper et al., 1988). The 267-bp
cep probe was derived from EcoR1 (Fermentas) digested pSC01
plasmid.
Pulsed-Field Gel Electrophoresis (PFGE)
PFGE ofV. choleraeO139 was performed as described previously
for V. cholerae O1 (Cooper et al., 2006). PFGE profiles were
analyzed using the BioNumerics version 4.0 software (Applied
Maths, Sint Martens Latem, Belgium). The tagged image file
formats were normalized by using the universal S. enterica
serotype Braenderup (H9812) size standard on each gel against
the reference in the database. In the dendrogram analysis,
the PFGE profiles were matched using the Dice coefficient
and unweighted pair group method using arithmetic averages
(UPGMA). Clustering of PFGE profiles was made using 1.5%
band position tolerance window and 1.5% optimization.
RESULTS
Identification
Conventional serology and multiplex PCRs employed in this
study confirmed all the isolates as V. cholerae O139.
Antimicrobial Susceptibility
In the antimicrobial susceptibility testing by disc diffusion assay,
more than 60% of the V. cholerae O139 isolates were resistant
to ampicillin, furazolidone, and nalidixic acid displaying the
antibiogram as AFzNa (Table 1). The susceptibility pattern of
V. cholerae O139 isolated during 2001 differed from the rest of
the study period by displaying resistance to chloramphenicol,
co-trimoxazole, and streptomycin. During the same year, 66%
of the isolates were susceptible to nalidixic acid. However, in
the subsequent years (2004–2006), all most all the isolates were
resistant to ampicillin, furazolidone, and nalidixic acid (Table 1).
For neomycin, 23 isolates showed reduced susceptibility and 19
TABLE 2 | CT genotypes of V. cholerae O139 based on DNA sequences of ctxB.
V. cholerae [Isolate No.] (year of isolation) No. of isolates Nucleotide at position Amino acid at position CT genotype
83 115 138 203 28 39 46 68
V. cholerae O1 [569B], classical 1 A C T C D H F T 1
V. cholerae O1 El Tor, [N16961] 1 A T T T D Y F I 3
V. cholerae O139 [37, 46, 103] (2001) 3 C C T C A H F T 4*
V. cholerae O139 [3722] (2004) 1 C C T C A H F T 4*
V. cholerae O139 [3705] (2004) 1 A C T C D H F T 1
V. cholerae O139 [5037] (2005) 1 A C T C D H F T 1
V. cholerae O139 [6080, 6127] (2006) 2 C C T C A H F T 4*
*New CT genotype.
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FIGURE 1 | Mapping of CTX genetic element consisting of cep, orfU, ace, zot, and ctxAB genes in V. cholerae O139 after digestion of chromosomal
DNA with HindIII (H), PstI (P), BglII (B), and probed with ctxA. (A) Eighteen V. cholerae O139 isolates had two intact copies (pink and brown) and one truncated
CTX elements (pink). (B) Six V. cholerae O139 isolates harbored single intact copy of the CTX element (pink and brown). (C) The isolate 46 had two intact copies (pink
and brown) and three copies of the truncated (pink) CTX elements. Restriction sites are abbreviated as B, H, and P for BglII, HindIII, and PstI, respectively. List of
probes used for hybridization was given at the right hand side. The number denotes length of the DNA fragments in Kb after digestion with the marked restriction
enzymes on the left hand side.
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remained susceptible (data not shown). The MIC values varied
considerably for ampicillin (4–12µg/ml), co-trimoxazole (4–
12µg/ml), nalidixic acid (3 to >256µg/ml), and streptomycin
(64 to >256µg/ml). MIC for chloramphenicol (2–4µg/ml) and
erythromycin (1–1.5µg/ml) remained low (Table 1).
Analysis of Virulence Loci, ICE and
Antimicrobial Resistance Encoding Genes
The O139 isolates uniformly harbored ctxA with an El Tor allele
of tcpA. In the MAMA-PCR, all the isolates were identified as CT
genotype 1. In addition, four isolates (37, 46, 103, and X) collected
in 2001 exhibited CT genotype 3 (Table 1). The amplified ctxB
gene from eight isolates was directly sequenced. The deduced
amino acid sequence analysis identified heterogeneity in the B
subunit of CT. Some of the 2004 and 2005 isolates had aspartic
acid (D), histidine (H), phenylalanine (F), and threonine (T) at
positions 28, 39, 46, and 68, respectively in the CtxB, which is
similar to the CT genotype 1 of the V. cholerae O1 classical 569B
strain (Table 2). However, the isolates representing 2001, 2004,
and 2006 had amino acids alanine (A), H, F, T at positions 28, 39,
46, 68, respectively, which has been classified as CT genotype 4.
This genotype was described in our previous report as genotype
5 with V. choleraeO139 isolates from Bangladesh (Bhuiyan et al.,
2009). Subsequently, this was corrected in our publication in 2010
(Raychoudhuri et al., 2010).
About 80% of the isolates possessed more than one allele of
rstR, one being the El Tor type (rstRET) and the other with rstRcalc
type. Interestingly, three 2001 isolates (37, 46, and 103) carried
all the three rstR alleles, i.e., rstRCl, rstRET , and rstRCalc. These
isolates belonged to a new ribotype (Table 1). ICE was present
in all the V. cholerae O139 isolates as confirmed by two sets of
primers. V. cholerae O139 isolated in 2001 that were resistant to
chloramphenicol, streptomycin and co-trimoxazole respectively
harbored floR, str, and dfr genes.
ctxA RFLP
Twenty four V. cholerae O139 isolated during 2004–2006
displayed two tandemly arranged copies of intact CTX prophages
with cep, orfU, ace, zot, and ctxAB as a 23Kb fragment
(Figure 1A). These CTX prophages were closely bordered with
a 5Kb truncated prophage (without ctxAB) as detected by the
cep probe (Table 1, Figure 1A). Seven V. cholerae O139 isolated
in 2001 had a single copy of CTX prophage as detected by
8 Kb ctx/cep probes (Table 1, Figure 1B). One isolate harbored
two entire copies of CTX prophages as detected by ctx probe
along with 3 truncated phages that were detected as three 5 Kb
fragments by cep probe (Table 1, Figure 1C). Mapping could not
be accomplished for 10 isolates with the applied strategy in this
study.
Chromosomal Location of CTX Prophages
Three of the 2001 isolates (37, 46, and 103) carried CTX
prophages on both the chromosomes, which were confirmed by
PCR with specific primers for chromosome I and II ofV. cholerae
(Maiti et al., 2006). In the rest of theV. choleraeO139 isolates, the
CTX prophages remained in chromosome 1. To our knowledge,
FIGURE 2 | Ribotyping of V. cholerae O139 isolates after digestion of
chromosomal DNA with BglI. Letter in parentheses against each isolate
indicate the ribotype number.
this is the first report indicating the presence of CTX prophages
on chromosome II in V. cholerae O139.
Ribotyping
V. cholerae O139 isolates exhibited three different ribotypes
(Table 1, Figure 2). Ribotype BII was predominant in 34 isolates,
while 5 isolates exhibited BI ribotype. All the isolates of 2004–
2005 exhibited ribiotype BII pattern (Table 1). Ribotype patterns
of 2001 isolates had mixture of BI (with 4 isolates) and BII (with
5 isolates). Interestingly, three isolates (37, 46, and 103) identified
in 2001 exhibited a new ribotype pattern (Table 1, Figure 2).
These three isolates had an extra DNA band around the 2-Kb
region (Figure 2). This could be the new ribotype BVIII of V.
cholerae O139.
Pulsed-Field Gel Electrophoresis (PFGE)
Among the 9 2001 isolates, 8 different PFGE profiles were
identified demonstrating the diversity of their genomes
(Figure 3, cluster A). However, 3 isolates of 2001 belongs to
ribotype BVIII were closely related in the PFGE. V. cholerae
O139 isolated during 2004–2006 had similar PFGE profiles
(Figure 3, cluster B), but diverged from the other isolates of
2001. A consistent correlation existed in both ribotyping and
PFGE methods as most of the isolates having BII ribotype
pattern were placed in clusters B. In addition, the dendrogram
displayed subtypes among V. cholerae O139 isolates with
the BII and BVIII ribotypes at about 97% similarity level
(Figure 3).
DISCUSSION
One of the phenotypic markers used in the epidemiology
of cholera is the antimicrobial susceptibility patterns. In this
study, V. cholerae O139 isolates were resistant to ampicillin,
furazolidone, and nalidixic acid, a trend observed in majority
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FIGURE 3 | PFGE of V. cholerae O139 isolates after digestion of chromosomal DNA with NotI. The TIFF image of the gel was analyzed using Bionumeric
software to generate the dendrogram. Percent similarity was shown at the left hand side.
of the V. cholerae O1 serotype Inaba isolated during 2004–2005
from different parts of India (Dutta et al., 2006). The O139
isolates identified in 1992 were resistant to chloramphenicol,
co-trimoxazole, and streptomycin (Mukhopadhyay et al., 1998).
The reemerged V. cholerae O139 during 1996–1997 in India and
Bangladesh showed susceptibility toward co-trimoxazole (Mitra
et al., 1998; Faruque et al., 2003a).
In V. cholerae O1 and O139, mobile ICE that carried
antimicrobial resistance genes in the variable region expressed
resistance to chloramphenicol, co-trimoxazole, and streptomycin
(Hochhut et al., 2001). In this study, ICE was detected in all
the O139 isolates. However, only some of the 2001 isolates were
resistant to chloramphenicol, streptomycin, and co-trimoxazole
and harbored floR, str, and dfr. These resistance-encoding genes
were not present in other isolates in the ICE variable region.
Early studies conducted during the emergence of V. cholerae
O139 in India showed a trend of resistance to neomycin
(Mukhopadhyay et al., 1998). In this study, the O139 isolates
were either susceptible or showed reduced susceptibility to
neomycin. As seen in previous reports, all the V. cholerae O139
isolates remained susceptible to norfloxacin, tetracycline, and
ciprofloxacin, which are used in the treatment of cholera (Basu
et al., 2000).
The CT genotype of V. cholerae O1 El Tor isolates from
many countries has changed from CT genotype 3 to 1 (Safa
et al., 2008; Raychoudhuri et al., 2009) and such changes were
detected in strains associated with large cholera outbreaks in
India and Bangladesh (Kumar et al., 2009; Nguyen et al., 2009;
Taneja et al., 2009). CT genotype 4 has closest homology to CT
genotype 1 with a difference of only single nucleotide (nucleotide
cytosine instead of adenine) at position 83 (Raychoudhuri
et al., 2010). Overall, our finding matches with the observation
made in V. cholerae O139 isolated during 1998, 2000, and
2002 from Bangladesh and Kolkata, respectively (Bhuiyan et al.,
2009; Raychoudhuri et al., 2010). Compared to El Tor, the
hybrid isolates with CT genotype 4 have caused larger cholera
outbreaks with more severe clinical symptoms (Kumar et al.,
2009; Nguyen et al., 2009; Taneja et al., 2009; Siddique et al.,
2010).
Epidemiologically, the CTX8 appear to be very important
as they show the genetic changes among V. cholerae O1/O139
that emerged during different periods (Faruque et al., 2000; Qu
et al., 2003). In the ctxA RFLP analysis, three prophages were
encountered in different years. The unusual genetic features of
the three 2001 isolates of V. choleraeO139 includes identification
of the new ribotype BVIII pattern, the presence of three rstR allele
types, CTX prophages of the classical type, and integration of
CTX prophage in both the chromosomes. Epidemiologically, the
new ribotypes of V. cholerae O1/O139 has been identified along
with changes in the CTX prophage or rstR allele (Faruque et al.,
1997). Considering several genetic events in the past, it has been
inferred that theV. choleraeO139may have multiple origins with
different progenitors (Faruque et al., 2003b; Garg et al., 2003; Qu
et al., 2003).
Genesis of V. cholerae O1 El Tor from the classical biotype,
the emergence of the serogroup O139, and existence of El Tor
that produces classical CT suggests that the V. cholerae is in a
continuous state of adaptability, resulting in generation of new
serogroups and/or new variants of the same serogroup. Our
results suggest that the genome of V. cholerae O139 is dynamic
and has undergone several changes since its emergence in 1992.
Continuous surveillance and proper monitoring of V. cholerae
O139 are however needed to detect subtle genetic changes in the
genomes and its implications in its epidemiology, pathogenesis
and persistence. Future studies should focus on epigenetic studies
to find answers to the question as to why the O139 serogroup has
disappeared from cholera endemic regions despite several genetic
changes.
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